spacer
home > ict > spring 2017 > word for word
PUBLICATIONS
International Clinical Trials

Word for Word

Juan Julián León: It’s true that globalisation is having an immediate impact on pharma, both in corporate and institutional environments. With each passing day, regulations become more global and this, in turn, directly affects the translation sector. Indeed, demand for translation services has not only risen, but these services have also had to evolve to adapt to this changing environment.

The translation sector now faces new obstacles, one of which is the need to continually attract and retain talent. Pharma translation is a much specialised field, and requires highly trained and experienced professionals. Translation companies expend great efforts maintaining and developing specialised multidisciplinary teams in this industry, including native translators for many languages, linguists, experts in medical and pharma regulations and terminology, reviewers, editors, layout designers, developers and so forth.

Another hurdle we face is the need to adapt to constantly changing terminology. The emergence of new illnesses, compositions and medicines demands that we continuously update our knowledge.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Juan Julián León is a renowned expert in the translation, localisation and intellectual property industry. Of particular note is his participation in the creation and expansion of one of the industry's top firms, SeproTec Multilingual Solutions, now present in 11 countries with over 400 employees. Today, Juan Julián continues in his role as Chief Executive Officer of the company and has participated in operations as crucial as its international expansion, the acquisition of the Polish firm Lidolang and the creation of SHIP Global IP, an innovative initiative in the intellectual property industry.
spacer
Juan Julián León
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino

Vilnius, Lithuania, and Copenhagen, Denmark – December 18th 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement